During the past decade, Aalborg Sygehus Nord conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Aalborg Sygehus Nord" are "Arm Spasticity" (1 trials), "Non-Insulin-Dependent Diabetes Mellitus" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Aalborg Sygehus Nord" in a lesser frequency.

Most popular intervention types in "Aalborg Sygehus Nord" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ATL-962" (1 trials), "Botulinum toxin type A" (1 trials) and "Orlistat" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aalborg Sygehus Nord" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Aalborg Sygehus Nord". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Aalborg Sygehus Nord, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Aalborg Sygehus Nord, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".